Noncoding RNAs in critical limb ischemia

D Pérez-Cremades, HS Cheng… - … , and vascular biology, 2020 - Am Heart Assoc
D Pérez-Cremades, HS Cheng, MW Feinberg
Arteriosclerosis, thrombosis, and vascular biology, 2020Am Heart Assoc
Peripheral artery disease, caused by chronic arterial occlusion of the lower extremities,
affects over 200 million people worldwide. Peripheral artery disease can progress into
critical limb ischemia (CLI), its more severe manifestation, which is associated with higher
risk of limb amputation and cardiovascular death. Aiming to improve tissue perfusion,
therapeutic angiogenesis held promise to improve ischemic limbs using delivery of growth
factors but has not successfully translated into benefits for patients. Moreover, accumulating …
Peripheral artery disease, caused by chronic arterial occlusion of the lower extremities, affects over 200 million people worldwide. Peripheral artery disease can progress into critical limb ischemia (CLI), its more severe manifestation, which is associated with higher risk of limb amputation and cardiovascular death. Aiming to improve tissue perfusion, therapeutic angiogenesis held promise to improve ischemic limbs using delivery of growth factors but has not successfully translated into benefits for patients. Moreover, accumulating studies suggest that impaired downstream signaling of these growth factors (or angiogenic resistance) may significantly contribute to CLI, particularly under harsh environments, such as diabetes mellitus. Noncoding RNAs are essential regulators of gene expression that control a range of pathophysiologies relevant to CLI, including angiogenesis/arteriogenesis, hypoxia, inflammation, stem/progenitor cells, and diabetes mellitus. In this review, we summarize the role of noncoding RNAs, including microRNAs and long noncoding RNAs, as functional mediators or biomarkers in the pathophysiology of CLI. A better understanding of these ncRNAs in CLI may provide opportunities for new targets in the prevention, diagnosis, and therapeutic management of this disabling disease state.
Am Heart Assoc